Ulipristal acetate (Esmya ®) intermittent treatment

Assessment Status Rapid review complete
Drug Ulipristal acetate
Brand Esmya®
Indication For the intermittent treatment of moderate to severe symptoms of uterine fibroids in adult women of reproductive age.
Assessment Process
Rapid review commissioned 17/05/2016
Rapid review completed 31/05/2016
Rapid review outcome Full Pharmacoeconomic Evaluation Not Recommended